63rd Day Of Lockdown

Maharashtra52667157861695 Tamil Nadu170828731119 Gujarat144686636888 Delhi140536771276 Rajasthan73004056167 Madhya Pradesh68593571300 Uttar Pradesh64973660169 West Bengal38161414278 Andhra Pradesh2886189256 Bihar273773313 Karnataka218270544 Punjab2081191340 Telangana1920116456 Jammu and Kashmir166880923 Odisha14386497 Haryana121380216 Kerala8975326 Assam549634 Jharkhand4051484 Uttarakhand349584 Chhatisgarh292670 Chandigarh2661874 Himachal Pradesh223634 Tripura1981650 Goa67190 Puducherry49170 Manipur3640 Meghalaya15121 Nagaland300 Arunachal Pradesh210 Mizoram110 Sikkim100
World Europe 11 May 2020 Men have higher chan ...

Men have higher chances of COVID-19 infection

REUTERS
Published May 11, 2020, 9:14 am IST
Updated May 11, 2020, 9:33 am IST
Recent study finds that men’s blood has a key enzyme used by coronavirus to infect cells in a higher quantity when compared to women’s
A lab technician makes a quick test on a blood sample to detect the new coronavirus. (AFP)
 A lab technician makes a quick test on a blood sample to detect the new coronavirus. (AFP)

London: Men’s blood has higher levels than women’s of a key enzyme used by the new coronavirus to infect cells, the results of a big European study showed on Monday — a finding which may help explain why men are more vulnerable to infection with COVID-19.

Angiotensin-converting enzyme 2 (ACE2) is found in the heart, kidneys and other organs. In COVID-19, the respiratory disease caused by the novel coronavirus is thought to play a role in how the infection progresses into the lungs.

 

The study, published in the European Heart Journal, also found that widely-prescribed drugs called ACE inhibitors or angiotensin receptor blockers (ARBs) did not lead to higher ACE2 concentrations and should therefore not increase the COVID-19 risk for people taking them.

ACE inhibitors and ARBs are widely prescribed to patients with congestive heart failure, diabetes or kidney disease. The drugs account for billions of dollars in prescription sales worldwide.

“Our findings do not support the discontinuation of these drugs in COVID-19 patients,” said Adriaan Voors, a professor of cardiology at the University Medical Center (UMC) Groningen in The Netherlands, who co-led the study.

The COVID-19 pandemic has infected more than 4 million people worldwide and killed almost 277,000, according to a Reuters tally. Death and infection tolls point to men being more likely than women to contract the disease and to suffer severe or critical complications if they do.

Analysing thousands of men and women, Voors’ team measured ACE2 concentrations in blood samples taken from more than 3,500 heart failure patients from 11 European countries.

The study had started before the coronavirus pandemic, the researchers said, and so did not include patients with COVID-19.

But when other research began to point to ACE2 as key to the way the new coronavirus gets into cells, Voors and his team saw important overlaps with their study.

“When we found that one of the strongest biomarkers, ACE2, was much higher in men than in women, I realised that this had the potential to explain why men were more likely to die from COVID-19 than women,” said Iziah Sama, a doctor at UMC Groningen who co-led the study.

ACE2 is a receptor on the surface of cells which binds to the new coronavirus and allows it to enter and infect cells.

Sama and Voors noted that as well as in the lung, ACE2 is found in the heart, kidneys, in tissues lining blood vessels, and in particularly high levels in the testes.

They said its presence in the testes might partially explain higher ACE2 concentrations in men, and why men are more vulnerable to COVID-19.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT